Perifect
Minimally Invasive Devices for Pericardial Therapies
Company Overview
Snapshot
Founded in October 2010 by Karl-Heinz Kuck, Francesco Maisano, Liat Tsoref, and Yossi Gross, Perifect operated with 1–10 employees. The company ceased operations in December 2019.
Business overview
Perifect developed minimally invasive medical devices for pericardial and epicardial therapies, focusing on the cardiovascular and cardiology sectors. Their core product, the PeriCardioScope, was a video-guided pericardial access device designed to enable safe navigation to the pericardium and penetration into the pericardial space without harming adjacent organs. The company targeted healthcare providers within the Health Tech & Life Sciences market.
Log in to access full profile ›Company Intelligence Q&A
- What was Perifect's primary focus?
- Perifect focused on developing minimally invasive devices for pericardial and epicardial therapies, specifically targeting cardiovascular and cardiology applications.
- When was Perifect founded?
- Perifect was founded in October 2010.
- What was the status of Perifect?
- Perifect ceased to operate in December 2019.
- Who were the co-founders of Perifect?
- The co-founders of Perifect included Karl-Heinz Kuck and Francesco Maisano.
- What was Perifect's flagship product?
- Perifect's flagship product was the PeriCardioScope, a video-guided pericardial access device designed for safe navigation and penetration into the pericardial space.